Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Computational Assessment of the Effects of GABA Receptor Modulation in Posttraumatic Stress Disorder
NCT06852469Phase 4Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2025
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorazepam in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Jul 2025; status: recruiting.
02
Drugs
lorazepam
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06852469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06852469.